We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
751
DELISTED
Juniper Networks
JNPR
| $337K | 0.05% |
+11,808
| New | +$372K |
|
752
Sturm, Ruger & Co
RGR
$593M
| $337K | 0.05% |
5,289
+936
| +22% | +$62.9K |
|
753
Zoom
ZM
$30.6B
| $337K | 0.05% |
+3,122
| New | +$329K |
|
|
MODN
754
DELISTED
MODEL N, INC.
MODN
| $337K | 0.05% |
13,191
-30,993
| -70% | -$772K |
|
755
Arthur J. Gallagher & Co
AJG
$63.6B
| $336K | 0.05% |
+2,063
| New | +$342K |
|
|
CFB
756
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $336K | 0.05% |
25,478
+11,256
| +79% | +$152K |
|
|
CADE
757
DELISTED
Cadence Bank
CADE
| $335K | 0.05% |
14,260
-14,729
| -51% | -$379K |
|
758
MKS Inc
MKSI
$20.6B
| $335K | 0.05% |
+3,261
| New | +$380K |
|
759
Starbucks
SBUX
$120B
| $335K | 0.05% |
+4,391
| New | +$337K |
|
760
Victory Capital Holdings
VCTR
$6.65B
| $335K | 0.05% |
13,886
-8,246
| -37% | -$222K |
|
761
OGE Energy
OGE
$9.71B
| $334K | 0.05% |
8,660
-1,243
| -13% | -$49.4K |
|
|
TPC
762
Tutor Perini Cor
TPC
$5.21B
| $333K | 0.05% |
37,898
+9,929
| +36% | +$95.9K |
|
|
CTLP
763
DELISTED
Cantaloupe
CTLP
| $332K | 0.05% |
+59,306
| New | +$315K |
|
764
ONE Gas
OGS
$5.04B
| $332K | 0.05% |
+4,092
| New | +$350K |
|
765
Verra Mobility
VRRM
$744M
| $332K | 0.05% |
21,135
-4,829
| -19% | -$73.4K |
|
766
Align Technology
ALGN
$12.3B
| $330K | 0.05% |
1,394
+433
| +45% | +$133K |
|
767
Taboola.com
TBLA
$1.11B
| $329K | 0.05% |
129,958
-165,415
| -56% | -$607K |
|
768
Cheniere Energy
LNG
$52.9B
| $328K | 0.05% |
2,466
-5,540
| -69% | -$755K |
|
|
DCPH
769
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $328K | 0.05% |
24,923
+6,210
| +33% | +$68.5K |
|
770
Interparfums
IPAR
$3.94B
| $327K | 0.05% |
+4,471
| New | +$342K |
|
771
Intuitive Surgical
ISRG
$134B
| $327K | 0.05% |
+1,628
| New | +$382K |
|
772
Labcorp
LH
$25.9B
| $326K | 0.05% |
1,621
+465
| +40% | +$99.1K |
|
773
Skywest
SKYW
$4.34B
| $326K | 0.05% |
15,342
-1,788
| -10% | -$47K |
|
774
Oxford Industries
OXM
$552M
| $325K | 0.05% |
+3,667
| New | +$329K |
|
775
American Airlines Group
AAL
$10.6B
| $323K | 0.05% |
+25,468
| New | +$424K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.